Warfarin purple toe

Purple toe syndrome is a rarely reported adverse effect of warfarin. In all described cases, the syndrome occurred relatively quickly after initiation of warfarin with little recommendation for treatment in patients needing continued anticoagulation. We encountered a patient who developed purple toes after 1 year of warfarin therapy.

Purple toes syndrome is an extremely uncommon, nonhemorrhagic, cutaneous complication associated with warfarin therapy. It is characterized by

purple toe syndrome. Severe bleeding, unusual pain or swelling, and severe headache require immediate medical attention. The dosage of warfarin

by DR Ryu Cited by 5Purple toe syndrome is an extremely rare complication of warfarin therapy. The occurrence of purple toe syndrome is characterized by a sudden appearance

Purple toe syndrom caused by 1 digoxin 2 heparin 3 warfarin 4 propranolol 5 riviraxaban.

A patient who developed purple toes after 1 year of warfarin therapy was encountered, and fondaparinux was substituted with prompt resolution of all his symptoms and this is the first case describing late onset purple toe syndrome with warFarin with successful substitution with fondAParinux. Purple toe syndrome is a rarely reported adverse effect of warfarin. In all described cases, the

Warfarin anticoagulation is widely used for many clinical indications. Warfarin Evidence of skin necrosis or purple toe syndrome. Pregnancy. Women of

by MA Di Cato 2024 Cited by 18therapy with sodium warfarin (Coumadin). During The toes on bath feet and the external A rare complication of coumarin therapy is the so-called purple toes

Purple toes syndrome is an extremely uncommon, nonhemorrhagic, cutaneous complication associated with warfarin therapy. It is characterized by the sudden appearance of bilateral, painful, purple lesions on the toes and sides of the feet that blanch with pressure. The syndrome usually develops 3 8 weeks after the start of warfarin therapy.